Peer-Reviewed and Published Research

Top-Line Results from Pivotal Trial of BT-001, 2022
Positive primary and secondary endpoint data from pivotal clinical trial for type 2 diabetes digital therapeutics.

Pilot Data Presented at Endocrine 2020
This study represents an important milestone on the path to regulatory approval, demonstrating that a software-only product configuration delivering behavioral therapy can produce meaningful outcomes in patients.

Contact Us
Have a question or want to learn more? Get in touch and let us know what's on your mind.